Victorian researchers have characterised a protein, VDAC2, as a key component of the apoptosis process used by anti-cancer agents such as venetoclax. Walter and Eliza Hall Institute scientists have identified VDAC2 (voltage-dependent anion channel 2) as important for the function of the protein BAX to drive apoptotic cell death. BAX is one of two essential ...
Already a member?
Enter your email to keep reading.